BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17280601)

  • 1. The treatment of breakthrough pain.
    McCarberg BH
    Pain Med; 2007; 8 Suppl 1():S8-13. PubMed ID: 17280601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and diagnosis of breakthrough pain.
    Payne R
    Pain Med; 2007; 8 Suppl 1():S3-7. PubMed ID: 17280600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough pain in the management of chronic persistent pain syndromes.
    Webster LR
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S116-22. PubMed ID: 18611099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case studies in breakthrough pain.
    Driver LC
    Pain Med; 2007; 8 Suppl 1():S14-8. PubMed ID: 17280598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer.
    Portenoy RK; Taylor D; Messina J; Tremmel L
    Clin J Pain; 2006; 22(9):805-11. PubMed ID: 17057563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapeutic management of breakthrough pain in patients with chronic persistent pain.
    Fishbain DA
    Am J Manag Care; 2008 May; 14(5 Suppl 1):S123-8. PubMed ID: 18611100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakthrough pain in opioid-treated chronic non-malignant pain patients referred to a multidisciplinary pain centre: a preliminary study.
    Højsted J; Nielsen PR; Eriksen J; Hansen OB; Sjøgren P
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1290-6. PubMed ID: 16999839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
    Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
    Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids and treatment of chronic pain: understanding pain patterns and the role for rapid-onset opioids.
    Simon S
    MedGenMed; 2005 Nov; 7(4):54. PubMed ID: 16614676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.
    Slatkin NE; Xie F; Messina J; Segal TJ
    J Support Oncol; 2007; 5(7):327-34. PubMed ID: 17708123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl buccal tablet: faster rescue analgesia for breakthrough pain?
    Lecybyl R; Hanna M
    Future Oncol; 2007 Aug; 3(4):375-9. PubMed ID: 17661711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing breakthrough pain: a clinical review with three case studies using oral transmucosal fentanyl citrate.
    Rhiner M; Palos G; Termini M
    Clin J Oncol Nurs; 2004 Oct; 8(5):507-12. PubMed ID: 15515284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent development in therapeutics for breakthrough pain.
    Davis MP
    Expert Rev Neurother; 2010 May; 10(5):757-73. PubMed ID: 20420495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of breakthrough pain vs. pharmacokinetics of oral morphine: implications for management.
    Zeppetella G
    Eur J Cancer Care (Engl); 2009 Jul; 18(4):331-7. PubMed ID: 19473378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the pharmacokinetic profile of transmucosal fentanyl formulations.
    Moore N; Darwish M; Amores X; Schneid H
    Curr Med Res Opin; 2012 Nov; 28(11):1781-90. PubMed ID: 23020252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough pain: progress in management.
    Lossignol DA; Dumitrescu C
    Curr Opin Oncol; 2010 Jul; 22(4):302-6. PubMed ID: 20489619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough pain in cancer patients.
    Zeppetella G
    Clin Oncol (R Coll Radiol); 2011 Aug; 23(6):393-8. PubMed ID: 21227666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact and management of breakthrough pain in cancer.
    Zeppetella G
    Curr Opin Support Palliat Care; 2009 Mar; 3(1):1-6. PubMed ID: 19365156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.